1.
Pugsley D, Norris KC, Garcia-Garcia G, Agodoa L: Global approaches for understanding the disproportionate burden of chronic kidney disease. Ethn Dis 2009;19(suppl 1):S1-S2.
2.
Crews DC, Charles RF, Evans MK, Alan B, Zonderman AB, Powe NR: Poverty, race, and CKD in a racially and socioeconomically diverse urban population. Am J Kidney Dis 2010:55:992-1000.
3.
Sachs JD: Macroeconomics and Health: Investing in Health for Economic Development - Report of the Commission on Macroeconomics and Health. Geneva, WHO, 2001.
4.
Kalantar-Zadhe K, Block G, Humphreys MH, Kopple JD: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003;63:793-808.
5.
Hsu CY, Lin F, Vittinghof E, Shlipak MG: Racial differences in the progression from chronic renal Insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 2003;14:2902-2907.
6.
Norris K, Nissenson AR: Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol 2008;19:1261-1270.
7.
Bruce MA, Beech BM, Crook ED, Sims M, Wyatt SB, Michael F. Flessner MF, Taylor HA, Williams DR, Akylbekova EL, Ikizler TA: Association of socioeconomic status and CKD among African Americans: the Jackson Heart Study. Am J Kidney Dis 2010;55:1001-1008.
8.
Volkova N, McClellan W, Klein M, Flanders D, Kleinbaum D, Soucie JM, Presley R: Neighborhood poverty and racial differences in ESRD incidence. J Am Soc Nephrol 2008;19:356-364.
9.
Caskey FJ: Renal replacement therapy: can we separate the effects of social deprivation and ethnicity? Kidney Int Suppl 2013;3:246-249.
10.
Sabanayagam C, Lim SC, Wong TY, Lee J, Shankar A, Tai ES: Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease. Nephrol Dial Transplant 2010;25:2564-2570.
11.
Gao S, Manns BJ, Culleton BF, Tonelli M, Quan H, Crowshoe L, Ghali WA, Svenson LW, Hemmelgarn BR: Prevalence of chronic kidney disease and survival among aboriginal people. J Am Soc Nephrol 2007;18:2953-2959.
12.
McDonald S: Incidence and treatment of ESRD among indigenous peoples of Australasia. Clin Nephrol 2010;74(suppl 1):S28-S31.
13.
Collins JF: Kidney disease in Maori and Pacific people in New Zealand. Clin Nephrol 2010;74(suppl 1):S61-S65.
14.
Weil EJ, Nelson RG: Kidney disease among the indigenous peoples of Oceania. Ethn Dis 2006;16(suppl 2):S24-S30.
15.
United States Renal Data System: USRDS 2006 Annual Data Report. Bethesda, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 2013.
16.
Kasiske BL, Rith-Najarian S, Casper ML, Croft JB: American Indian heritage and risk factors for renal injury. Kidney Int 1998;54:1305-1310.
17.
Nelson RG, Morgenstern H, Bennett PH: An epidemic of proteinuria in Pima Indians with type 2 diabetes mellitus. Kidney Int 1998;54:2081-2088.
18.
Scavini M, Shah VO, Stidley CA, Tentori F, et al: Kidney disease among the Zuni Indians: the Zuni Kidney Project. Kidney Int 2005;68(suppl 97):126-131.
19.
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AYM, Yang CW: Chronic kidney disease: global dimension and perspectives. Lancet 2013;382:260-272.
20.
Almaguer M, Herrera R, Orantes CM: Chronic kidney disease of unknown etiology in agricultural communities. MEDICC Rev 2014;16:9-15.
21.
Ulasi II, Ijoma CK, Onodugo OD, Arodiwe EB, et al: Towards prevention of chronic kidney disease in Nigeria: a community-based study in Southeast Nigeria. Kidney Int Suppl 2013;3:195-201.
22.
Otieno LS, McLigeyo SO, Luta M: Acute renal failure following the use of herbal medicines. East Afr Med J 1991;6:993-998.
23.
Obrador GT, Garcia-Garcia G, Villa AR, Rubilar X, et al: Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) Mexico and comparison with KEEP US. Kidney Int 2010;77(suppl 116):S2-S8.
24.
Gutierrez-Padilla JA, Mendoza-Garcia M, Plascencia-Perez S, Renoirte-Lopez K, et al: Screening for CKD and cardiovascular disease risk factors using mobile clinics in Jalisco, Mexico. Am J Kidney Dis 2010;55:474-484.
25.
Garcia-Garcia G, Gutierrez-Padilla AJ, Chavez-Iñiguez J, Perez-Gomez HR, Mendoza-García M, Gonzalez-De la Peña MM, Tonelli M: Identifying undetected cases of CKD in Mexico: targeting high-risk populations. Arch Med Res 2013;44:623-627.
26.
Amato D, Alvarez-Aguilar C, Castañeda-Limones R, et al: Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int 2005;68(suppl 97):11-17.
27.
Hoy W, McDonald SP: Albuminuria: marker or target in indigenous populations. Kidney Int 2004;66(suppl 92):S25-S31.
28.
McDonald SP, Maguire GP, Hoy WE: Renal function and cardiovascular risk markers in a remote Australian Aboriginal community. Nephrol Dial Transplant 2003;18:1555-1561.
29.
Hoy WE, Samuel T, Mott SA, Kincaid-Smith PS, Fogo AB, Dowling JP, Hughson MD, Sinniah R, Pugsley DJ, Kirubakaran MG, Douglas-Denton RN, Bertram JF: Renal biopsy findings among Indigenous Australians: a nationwide review. Kidney Int 2012;82:1321-1331.
30.
Hoy WE, Hughson MD, Zimanyi M, et al: Distribution of volume of individual glomeruli in kidneys at autopsy: association with age, nephron number, birthweight and body mass index. Clin Nephrol 2010;74(suppl 1):S105-S112.
31.
Lackland DT, Bendall HE, Osmond C, Egan BM, Barker DJ: Low birth weights contribute to high-rates of early-onset of chronic renal failure in the Southeastern United States. Arch Intern Med 2000;160:1472-1476.
32.
Bhargava SK, Sachdev HS, Fall CH, et al: Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 2004;350:865-875.
33.
Jafar TH, Chaturvedi N, Hatcher J, et al: Proteinuria in South Asian children: prevalence and determinants. Pediatr Nephrol 2005;20:1458-1465.
34.
Jafar TH, Islam M, Poulter N, et al: Children in South Asia have higher body mass-adjusted blood pressure levels than white children in the United States: a comparative study. Circulation 2005;111:1291-1297.
35.
Liyanage T, Ninomiya T, Jha V, Patrice HM, Okpechi I, Zhao M, Lv J, Garg AX, Knight J, Gallagher M, Kotwal S, Cass A, Perkovic V: Worldwide access to treatment for end stage kidney disease: a systematic review. In press.
36.
Barsoum RS: Chronic kidney disease in the developing world. N Engl J Med 2006;354:997-999.
37.
Cusumano AM, Garcia-Garcia G, Gonzalez-Bedat MC, Marinovich S, et al: Latin American Dialysis and Transplant Registry: 2008 prevalence and incidence of end-stage renal disease and correlation with socioeconomic indexes. Kidney Int Suppl 2013;3:153-156.
38.
Jha V: Current status of end-stage renal disease care in India and Pakistan. Kidney Int Suppl 2013;3:157-160.
39.
Garcia GG, Harden PN, Chapman JR; World Kidney Day 2012 Steering Committee: The global role of kidney transplantation. Lancet 2012;379:e36-e38.
40.
Yeates KE, Cass A, Sequist TD, McDonald SP, Jardine MJ, Trpeski L, Ayanian JZ: Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation. Kidney Int 2009;76:659-664.
41.
Jha V: Current status of chronic kidney disease care in South-East Asia. Semin Nephrol 2009;29:487-496.
42.
Garcia-Garcia G, Monteon-Ramos JF, Garcia-Bejarano H, Gomez-Navarro B, Hernandez-Reyes I, Lomeli AM, et al: Renal replacement therapy among disadvantaged populations in Mexico: a report from the Jalisco Dialysis and Transplant Registry (REDTJAL). Kidney Int 2005;68(suppl 97):S58-S61.
43.
Ramachandran R, Jha V: Kidney Transplantation is associated with catastrophic out of pocket expenditure in India. PLoS One 2013;8:e67812.
44.
McDonald SP, Russ GR: Burden of end-stage renal disease among indigenous peoples in Australia and New Zealand. Kidney Int 2003;63(suppl 83):S123-S127.
45.
Chou SH, Tonelli M, Bradley JS, Gourishankar S, Hemmelgarn BR: Quality of care among aboriginal hemodialysis patients. Clin J Am Soc Nephrol 2006;1:58-63.
46.
Rodriguez RA, Sen S, Mehta K, Moody-Ayers S, Bacchetti P, O'Hare AM: Geography matters: relationships among urban residential segregation, dialysis facilities, and patient outcomes. Ann Intern Med 2007;146:493-501.
47.
Mehrotra R, Story K, Guest S, Fedunyszyn M: Neighborhood location, rurality, geography and outcomes of peritoneal dialysis patients in the United States. Perit Dial Int 2012;32:322-331.
48.
Garcia-Garcia G, Briseño-Renteria G, Luquin-Arellano VH, Gao Z, Gill J, Tonelli M: Survival among patients with kidney failure in Jalisco. J Am Soc Nephrol 2007;18:1922-1927.
49.
Parameswaran S, Geda SB, Rathi M, Kohli, HS Gupta KL, Sakhuja V, Jha V: Referral pattern of end-stage renal disease patients and its impact on outcome at a public sector hospital. Nat Med J India 2011;24:208-213.
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.